SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse-type gastric cancer susceptibility (Q84409811)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse-type gastric cancer susceptibility (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

7

Bo Youl Choi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

3

Minjin Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Byungho Lim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Seung-Moo Noh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Woo Ho Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Chunhwa Ihm

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Yong Sung Kim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Changwon Kang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

4248-4255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

The urokinase-type plasminogen activator system in cancer metastasis: a review

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Protein inhibitors of proteinases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Urokinase‐type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Pathology and molecular biology of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Polymorphisms in the genes of the urokinase plasminogen activation system in relation to colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Plasminogen activator inhibitor-1 4G/5G polymorphism and susceptibility to endometriosis in the Italian population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Regulatory polymorphisms in extracellular matrix protease genes and susceptibility to rheumatoid arthritis: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

No association between the promoter polymorphisms of PAI-1 gene and sporadic Alzheimer's disease in Chinese Han population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25213

7 January 2021

Identifiers

DOI

10.1002/CNCR.25213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20549826%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference